With Stringent Oversight, Heritable Human Genome Editing Could Be Allowed for Serious Conditions
Clinical trials for genome editing of the human germline – adding, removing, or replacing DNA base pairs in gametes or early embryos – could be permitted in the future, but only for serious conditions under stringent oversight, says a new report from the National Academy of Sciences and the National Academy of Medicine.
More from Science & TechnologyMore posts in Science & Technology »
Be First to Comment